From September 2002 to July 2010 , 1712 patients < 22 years old with stage I-IIA with bulk , I-IIAE , I-IIB , and IIIA-IVA with or without doxorubicin , bleomycin , vincristine , etoposide , prednisone , and cyclophosphamide were enrolled .